Vestibular Schwannoma Clinical Trials 2023

Browse 53 Vestibular Schwannoma Medical Studies Across 89 Cities

1 Phase 3 Trial · 151 Vestibular Schwannoma Clinics

Reviewed by Michael Gill, B. Sc.
10 Vestibular Schwannoma Clinical Trials Near Me
Top Hospitals for Vestibular Schwannoma Clinical Trials
Image of Massachusetts General Hospital in Massachusetts.
Massachusetts General Hospital
3Active Trials
3All Time Trials for Vestibular Schwannoma
2009First Vestibular Schwannoma Trial
Image of Massachusetts Eye and Ear Infirmary in Massachusetts.
Massachusetts Eye and Ear Infirmary
2Active Trials
3All Time Trials for Vestibular Schwannoma
2018First Vestibular Schwannoma Trial
Image of University of Utah in Utah.
University of Utah
Salt Lake City
2Active Trials
3All Time Trials for Vestibular Schwannoma
2013First Vestibular Schwannoma Trial
Image of Specialty Physician Associates in Pennsylvania.
Specialty Physician Associates
2Active Trials
0All Time Trials for Vestibular Schwannoma
2022First Vestibular Schwannoma Trial
Image of Vanderbilt University Medical Center in Tennessee.
Vanderbilt University Medical Center
2Active Trials
1All Time Trials for Vestibular Schwannoma
2021First Vestibular Schwannoma Trial
Top Cities for Vestibular Schwannoma Clinical Trials
Image of Baltimore in Maryland.
8Active Trials
Centers for Advanced ENT Care (CAdENT)Top Active Site
Image of Boston in Massachusetts.
7Active Trials
Massachusetts General HospitalTop Active Site
Vestibular Schwannoma Clinical Trials by Phase of TrialVestibular Schwannoma Clinical Trials by Age Group
< 18 Vestibular Schwannoma Clinical Trials
2Active Vestibular Schwannoma Clinical Trials
Most Recent Vestibular Schwannoma Clinical TrialsTop Treatments for Vestibular Schwannoma Clinical Trials
Treatment Name
Active Vestibular Schwannoma Clinical Trials
All Time Trials for Vestibular Schwannoma
First Recorded Vestibular Schwannoma Trial
Rapid Acoustic Pulse (RAP)
SAM Ultrasound Device and Diclofenac Patch
Stim, then Sham, then daily Stim
Targeted Muscle Reinnervation

What Are Vestibular Schwannoma Clinical Trials?

This is a particular kind of benign (non-cancerous) brain tumor, also known as an auditory neuroma. A benign brain tumor is an abnormal development in the brain that typically develops slowly over a long period of time and does not spread to other body organs. An acoustic neuroma (vestibular schwannoma) is a benign tumor that grows on the vestibular and auditory nerves that connect your inner ear to your brain. The tumor's strain on the nerve might result in hearing loss and imbalance.

Why is Vestibular Schwannoma Being Studied Through Clinical Trials?

Non-pulsatile tinnitus and adult-onset sensorineural hearing loss are the usual symptoms of vestibular schwannoma. In other people, this remains unreported, and the lesion doesn't show up until it's considerably bigger and exhibiting signs of mass effect. Possible causes include hydrocephalus brought on by effacement of the fourth ventricle as well as cerebellar and brainstem symptoms, such as cranial nerve dysfunction. Vestibular Schwannoma Clinical Trials help determine suitable treatment options as per patient requirements.

What Are the Types of Treatments Available for Vestibular Schwannoma?

Vestibular Schwannoma comes in two varieties: unilateral and sporadic acoustic neuromas. In 95% of patients, these tumors exclusively spread to one side of the body. They are the result of random, non-heritable mutations. They often appear on imaging as a solid nodular mass with an intracanalicular component that frequently causes the porus acusticus to enlarge. When they are bigger, cystic degeneration may be present, and they often exhibit strong contrast enhancement. There may also be hemorrhagic patches, although calcification is usually absent.

What Are Some Recent Breakthrough Clinical Trials for Vestibular Schwannoma?

2011: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma - This study examines proton radiation, a different form of radiation that is known to protect nearby healthy tissues from radiation. To enhance localization of the tiny tumor target, proton radiation will be administered using fractionated stereotactic radiotherapy (FSRT). Radiation from proton therapy is seldom felt outside of the tumor's immediate vicinity. By doing this, patients may have fewer adverse effects than they would with conventional radiation therapy. In this study, we want to investigate the effects of fractionated proton radiation on long-term tumor growth control and hearing preservation.

2018: Study of Aspirin in Patients with Vestibular Schwannoma - This phase II prospective, double-blind, randomized, longitudinal trial examines if giving aspirin to VS patients can prevent or reduce the formation of tumors while preserving or enhancing hearing.

Who Are Some of the Key Research Institutions Conducting Vestibular Schwannoma Clinical Trial Research?

Haukeland University Hospital - The primary goal of their research is to deliver high-quality healthcare in a safe manner. According to national standards, a typical 4-5% (NOK 500 mill) of the whole budget is allotted for research activities. In terms of research output, it is the second-largest university hospital in Norway. In addition, Haukeland, the University Hospital and the University of Bergen collaborate closely to bring together multidisciplinary research teams.

Johns Hopkins University - America's first research institution was established on the tenet that by pursuing great ideas and sharing them, we may improve the state of the world. Students and teachers have collaborated on discoveries that have enhanced lives for more than 140 years. Since 1979, researchers at the university's Applied Physics Laboratory and nine academic departments have helped it lead the nation in government funding for research, including Vestibular Schwannoma clinical trials.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: August 29th, 2023

References1 Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9. doi: 10.1016/j.apmr.2007.11.005. Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia. Ann Thorac Surg. 2015 Jun;99(6):1953-60. doi: 10.1016/j.athoracsur.2015.02.074. Epub 2015 Apr 23. Byun TM, Hitchcock ER. Investigating the use of traditional and spectral biofeedback approaches to intervention for /r/ misarticulation. Am J Speech Lang Pathol. 2012 Aug;21(3):207-21. doi: 10.1044/1058-0360(2012/11-0083). Epub 2012 Mar 21. Harel D, Hitchcock ER, Szeredi D, Ortiz J, McAllister Byun T. Finding the experts in the crowd: Validity and reliability of crowdsourced measures of children's gradient speech contrasts. Clin Linguist Phon. 2017;31(1):104-117. doi: 10.3109/02699206.2016.1174306. Epub 2016 Jun 7. McAllister Byun T. Efficacy of Visual-Acoustic Biofeedback Intervention for Residual Rhotic Errors: A Single-Subject Randomization Study. J Speech Lang Hear Res. 2017 May 24;60(5):1175-1193. doi: 10.1044/2016_JSLHR-S-16-0038. Dugan SH, Silbert N, McAllister T, Preston JL, Sotto C, Boyce SE. Modelling category goodness judgments in children with residual sound errors. Clin Linguist Phon. 2019;33(4):295-315. doi: 10.1080/02699206.2018.1477834. Epub 2018 May 24. Hitchcock ER, Harel D, Byun TM. Social, Emotional, and Academic Impact of Residual Speech Errors in School-Aged Children: A Survey Study. Semin Speech Lang. 2015 Nov;36(4):283-94. doi: 10.1055/s-0035-1562911. Epub 2015 Oct 12. McAllister Byun T, Tiede M. Perception-production relations in later development of American English rhotics. PLoS One. 2017 Feb 16;12(2):e0172022. doi: 10.1371/journal.pone.0172022. eCollection 2017. Harel D, Hitchcock ER, Szeredi D, Ortiz J, McAllister Byun T. Finding the experts in the crowd: Validity and reliability of crowdsourced measures of children's gradient speech contrasts. Clin Linguist Phon. 2017;31(1):104-117. Epub 2016 Jun 7. Byun TM, Hitchcock ER, Swartz MT. Retroflex versus bunched in treatment for rhotic misarticulation: evidence from ultrasound biofeedback intervention. J Speech Lang Hear Res. 2014 Dec;57(6):2116-30. doi: 10.1044/2014_JSLHR-S-14-0034.